<DOC>
	<DOC>NCT01443325</DOC>
	<brief_summary>In the present placebo-controlled cross-over study the researchers intend to investigate analgesic and sensory effects of a lidocaine patch in patients with severe persistent inguinal post-herniorrhaphy pain.</brief_summary>
	<brief_title>Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Males &gt; 18 yrs ASA (American Society´s of Anesthesiology´s classification) scores IIII, with severe Pain for more than six months and with average daily pain intensities (numerical rating scale [NRS] 010 points) during rest or during movement &gt; 6. History of an allergic reaction or intolerance to amide local anesthetics or vehicle ingredients in the patches Use of class I antiarrhythmic drugs (e.g., tocainide and mexiletine) Severe cardiac impairment, e.g., NYHA (New York Heart Association) Class ≥ III Inflamed or injured skin at the application site Known severe hepatic disorder (ChildPugh score &gt; 6) Known severe renal impairment, (creatinine clearance &lt; 30 mL/min) Signs of cognitive impairment or known drug or ethanol abuse during the last 2 years.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Persistent Postherniorrhaphy inguinal Pain</keyword>
</DOC>